Evicenter
Opdivo (nivolumab) in Metastatic non-small cell lung cancer
Manufacturer
Bristol-Myers Squibb Company
Prescribing information
Opdivo (opens in a new tab)
Questions
60
Last updated

All questions

Pharmacology: Opdivo (nivolumab) in metastatic non-small cell lung cancer

4 questions · 3 sources

Mechanism

How do Opdivo and Yervoy work together?

Applies to First-line metastatic NSCLC in adults with no EGFR or ALK genomic tumor aberrations: OPDIVO with YERVOY (PD-L1 ≥1%) or OPDIVO with YERVOY and 2 cycles of platinum-doublet chemotherapy

What does hyaluronidase do in Opdivo Qvantig?

Applies to Metastatic NSCLC in adults with progression on or after platinum-based chemotherapy: OPDIVO QVANTIG monotherapy

Pharmacokinetics

How quickly is Opdivo Qvantig absorbed after injection?

Applies to Metastatic NSCLC in adults with progression on or after platinum-based chemotherapy: OPDIVO QVANTIG monotherapy

How do Opdivo Qvantig levels compare with Opdivo IV (Checkmate 67T)?

Applies to Metastatic NSCLC in adults with progression on or after platinum-based chemotherapy: OPDIVO QVANTIG monotherapy

Note: Checkmate 67T enrolled adults with previously treated advanced or metastatic clear cell renal cell carcinoma. The Opdivo HCP site cites its pharmacokinetic results in support of Opdivo Qvantig in previously treated metastatic NSCLC.